WE KNOW RARE.
WE THINK RARE.

We improve rare drug development and commercialization for industry and the families they serve.

For us, it’s personal.

Who We Are

Individually we are scientists, planners, creatives, writers, entrepreneurs, thinkers, and doers. We are also the parent of a child with a rare disease, we are the friend and family member of someone living with rare disease, we are the caregiver, we are the carrier, we are the face of rare disease — together, we are rareLife solutions.

Rare is personal

We have broad expertise and experience across more than 65 rare indications, including a growing list of oncology indications. We offer rare compassion and focus.

What We Do

From the small, hard-to-reach communities that define rare disease groups, the stories and the connections they forge require a different approach. We offer a broad suite of services that are designed to make drug development and commercialization better for industry and families. Our publications and scientific communications services are structured into six categories: Strategy, Community building, Scientific scaffold, Content development, Events, and Internal training. As the full-service rare scientific agency, we craft a tailored blend of innovative solutions to meet our clients’ unique needs.

Medical Publications

Our rare philosophy focuses on 3 things: Science, Community and Access. Our medical publications program considers all of those critical factors in the development and execution of our client’s programs.

Some of our rare publications principles include:

Scientific Communications

Our approach to scientific communications celebrates that rare patients, advocates, and caregivers are critical shapers of their rare disease ecosystem.

Meet Our team

When we say we live rare – we mean it. 70% of the rareLife team has been personally impacted by rare diseases. Here are some of our team’s stories.

How is rare disease different?

People always say rare is different. We agree.
That’s why you need an agency that thinks and acts differently.

our clients + Partners

Our approach to scientific communications celebrates that rare patients, advocates, and caregivers are critical shapers of their rare disease ecosystem.